PDCD1 and neoplasm: CH‐OD‐SSZ possesses both a direct tumor‐killing effect and immune‐stimulating activity to repolarize M2 macrophages and promote the activation of dendritic cells, efficiently suppressing the ascites progression and enhancing the anti‐PD‐1 immunotherapy in vivo.